Ambuja Cements Fund Raise of ₹15,000 Cr

Ambuja Cements Earnings Call Transcript: Key Takeaways

Ambuja delivers a resilient volume-led quarter despite monsoon headwinds, pivoting toward aggressive capacity expansion to 155 MTPA by FY30 while maintaining cost leadership.

Ambuja Cements Acquisition Worth ₹33.75 Cr

Ambuja Cements will acquire 26% of SWE Renewables for ₹33.75 Crore over 15 months. The move targets wind-powered captive electricity to reduce grid dependence.

Value

₹33.75 Cr

Execution

15 months (in one or more tranches)

Ambuja Cements Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue ₹9,197 Cr, flat YoY. EBITDA ₹1,271 Cr (-28%), margin 13.8% (vs 19.2%). Reported PAT ₹236 Cr (-90%). Company remains debt-free.

Ambuja Cements Results Update

Ambuja Cements posted Q2 FY27 consolidated revenue of Rs 9,197 Cr with EBITDA of Rs 1,271 Cr. The firm commissioned 4.6 MTPA of new capacity amid headwinds.

cement manufacturing capacity

4.6 MTPA

Ambuja Cements Q2 FY27 Results: Net Profit ₹236 Cr, Down 89.9% YoY

Ambuja Cements Ltd reported revenue from operations of ₹9,197 Cr (+0.2% YoY) and net profit of ₹236 Cr (-89.9% YoY) for Q2 FY27.

Key figure

Net profit ₹236 Cr · -89.9% YoY

Ambuja Cements Share Pledge

Ambuja Cements' promoters reported a share encumbrance involving a facility of USD 1.375 billion, equivalent to approximately 13,062.50 Crore. This is a promoter encumbrance disclosure.

Value

₹13,062 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr

MosChip Technologies Fund Raise of ₹112.2 Cr

MosChip Technologies approved a preferential issue of 50,50,686 equity shares at Rs.222 to 69 investors, raising about Rs.112.19 Crore. The board approval covers the fund raise, with an AGM/postal ballot dated 25 November 2026.

Value

₹112.2 Cr

Cholamandalam Investment & Finance Company Fund Raise

Cholamandalam's board approved a Qualified Institutions Placement fund raise on 28 October 2026, subject to shareholder postal ballot. The quantum, price and terms remain undetermined.